February 28, 2018

Goldplat plc Q&A with CEO Gerard Kisbey-Green (LON:GDP)

Goldplat plc (LON:GDP) Chief Executive Officer Gerard Kisbey-Green caught up with DirectorsTalk for an exclusive interview to discuss their interim results for the six months ended..

Widecells Group PLC Q&A with CEO João Andrade and Chairman Peter Presland

Widecells Group PLC (LON:WDC) Chief Executive Officer João Andrade and Chairman Peter Presland caught up with DirectorsTalk for an exclusive interview to discuss the recent Board..

Veltyco Group PLC Q&A with Whitman Howard (LON:VLTY)

Veltyco Group PLC (LON:VLTY) is the topic of conversation when Whitman Howard’s Equity Researcher Michael Campbell caught up with DirectorsTalk for an exclusive interview   Q1:..

Rainbow Rare Earths Ltd Q&A with CEO Martin Eales (LON:RBW)

Rainbow Rare Earths Ltd (LON:RBW) Chief Executive Officer Martin Eales caught up with DirectorsTalk for an exclusive interview to discuss their unaudited results for the six..

Solo Oil Plc Successfully raise £2m for Horse Hill Acquisition

Solo Oil plc (LON:SOLO), announced on 27 February 2018 the launch of a fundraising comprising of a Company sponsored placing (the “Placing”) in conjunction with an..

Safestyle UK plc Trading update – Zeus Capital Notes

Safestyle UK Plc (LON:SFE) has announced a trading update this morning warning of increased competitive pressures that have impacted order intake and are expected to result..

Savannah Resources Plc Scoping Study Underway into the Potential for a Mine Development

Savannah Resources plc (LON:SAV), the AIM quoted resource development company, has today announced that it has appointed internationally recognised Hatch to conduct a Scoping Study of..

OptiBiotix Health plc Capital Reorganisation

OptiBiotix Health plc (LON:OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes announced on 28 November 2017 that it intended to seek..

Allergy Therapeutics plc Prepares for Manufacturing and Clinical Development of Polyvac

Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, today announced that it has signed a contract with AGC Biologics (Heidelberg,..

ITV Plc Delivers Strong Operational Performance

ITV Plc (LON:ITV) Today announced its full year results for the year ended 31st December 2017. Full year performance delivers as expected · Total external revenue..

Search

Funds

February 28, 2018

Search

Funds

February 28, 2018

FTSE 100

Funds